International Scholarly Research Notices

Table of Contents

Filter by Subject
A
B
C
D
E
F
G
H
I
M
N
O
P
R
S
T
U
V
Z
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 817065
  • - Review Article

Fertility-Preserving Surgery in Patients with Early Stage Cervical Carcinoma

Spyridon Kardakis
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 245891
  • - Clinical Study

Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer

Mohamed I. El-sayed | Doaa W. Maximous | ... | Nabiel N. H. Mikhail
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 923013
  • - Retraction

Retracted: Review of Hypofractionated Radiotherapy for Prostate Cancer

ISRN Oncology
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 809370
  • - Research Article

A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing

Anthony C. Nichols | Michelle Chan-Seng-Yue | ... | John W. Barrett
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 902178
  • - Review Article

The Role of Radiotherapy and Chemotherapy in the Treatment of Primary Adult High Grade Gliomas: Assessment of Patients for These Treatment Approaches and the Common Immediate Side Effects

E. E. Philip-Ephraim | K. I. Eyong | ... | R. P. Ephraim
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 278093
  • - Review Article

Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells

John Maher
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 896202
  • - Clinical Study

Evaluation of Acute Locoregional Toxicity in Patients with Breast Cancer Treated with Adjuvant Radiotherapy in Combination with Pazopanib

Sharad Goyal | Sneha Shah | ... | Bruce G. Haffty
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 721612
  • - Research Article

The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma

Alexandra V. Sen'kova | Nadezhda L. Mironova | ... | Marina A. Zenkova
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 815234
  • - Clinical Study

Diagnostic Role of 18F-FECH-PET/CT Compared with Bone Scan in Evaluating the Prostate Cancer Patients Referring with Biochemical Recurrence

Mustafa Takesh | Khaldoun Odat Allh | ... | Christian Zechmann
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 450267
  • - Research Article

Molecular Profiles of Pre- and Postoperative Breast Cancer Tumours Reveal Differentially Expressed Genes

Margit L. H. Riis | Torben Lüders | ... | Ida R. K. Bukholm
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 428062
  • - Review Article

Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer

Rita Nahta
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 616310
  • - Review Article

Development of Safer Gene Delivery Systems to Minimize the Risk of Insertional Mutagenesis-Related Malignancies: A Critical Issue for the Field of Gene Therapy

Gaetano Romano
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 768190
  • - Clinical Study

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

Michiko Takakura | Akira Yokomizo | ... | Masaya Ono
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 982769
  • - Review Article

Serum Adiponectin Level and Different Kinds of Cancer: A Review of Recent Evidence

Vajihe Izadi | Elaheh Farabad | Leila Azadbakht
  • ISRN Oncology -
  • Special Issue
  • Volume 2012
  • - Article ID 581281
  • - Research Article

Preparation of 99mTc-Clomiphene Citrate as a Novel Agent for Breast Cancer Imaging

Ismail Taha Ibrahim | Mohamed Taha Elkolally | ... | Mohamed Hodhod Elsayed

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.